(Q48174091)

English

Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders - results of an open-label, parallel group, investigator-initiated, proof-of-concept study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders - results of an open-label, parallel group, investigator-initiated, proof-of-concept study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

1 reference

based on heuristic

inferred from title

Christian Brandt

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

author name string

Martin Schoendienst

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Monika Trentowska

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Mario Schrecke

4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Nora Fueratsch

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Karin Witte-Boelt

6

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Bernd Pohlmann-Eden

7

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Theodor W May

8

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

publication date

5 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

29

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

298-304

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

The psychiatric comorbidity of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

The epidemiology of the comorbidity of epilepsy in the general population

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Psychiatric comorbidity, health, and function in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Long-term efficacy of pregabalin in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire.

2 references

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

based on heuristic

inferred from DOI database lookup

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Assessment of anxiety in social interaction and being observed by others: The social interaction anxiety scale and the Social Phobia Scale

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Computer-assisted cognitive behavioral therapy for children with epilepsy and anxiety: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2013.08.004

7 January 2021

Identifiers

10.1016/J.YEBEH.2013.08.004

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

release_negdelb7l5bp7lupy6cocxzff4

1 reference

https://api.fatcat.wiki/v0/release/negdelb7l5bp7lupy6cocxzff4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/24012505

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48174091&oldid=2188647974"